Toth I - Search Results

1

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Among authors: toth i. Infect Immun. 2003 May;71(5):2373-83. doi: 10.1128/IAI.71.5.2373-2383.2003. Infect Immun. 2003. PMID: 12704107 Free PMC article.

2

The intersubunit region of the influenza virus haemagglutinin is recognized by antibodies during infection.

Nagy Z, Rajnavölgyi E, Hollósi M, Tóth GK, Váradi G, Penke B, Tóth I, Horváth A, Gergely J, Kurucz I. Nagy Z, et al. Among authors: toth gk, toth i. Scand J Immunol. 1994 Sep;40(3):281-91. doi: 10.1111/j.1365-3083.1994.tb03464.x. Scand J Immunol. 1994. PMID: 8091127

3

Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes.

Horvath A, Olive C, Wong A, Clair T, Yarwood P, Good M, Toth I. Horvath A, et al. Among authors: toth i. J Med Chem. 2002 Mar 14;45(6):1387-90. doi: 10.1021/jm0110441. J Med Chem. 2002. PMID: 11882009

4

Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology.

Hayman WA, Toth I, Flinn N, Scanlon M, Good MF. Hayman WA, et al. Among authors: toth i. Immunol Cell Biol. 2002 Apr;80(2):178-87. doi: 10.1046/j.1440-1711.2002.01067.x. Immunol Cell Biol. 2002. PMID: 11940119

5

A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies.

Olive C, Batzloff MR, Horváth A, Wong A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Among authors: toth i. Infect Immun. 2002 May;70(5):2734-8. doi: 10.1128/IAI.70.5.2734-2738.2002. Infect Immun. 2002. PMID: 11953422 Free PMC article.

6

Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies.

Olive C, Toth I, Jackson D. Olive C, et al. Among authors: toth i. Mini Rev Med Chem. 2001 Nov;1(4):429-38. doi: 10.2174/1389557013406666. Mini Rev Med Chem. 2001. PMID: 12369968 Review.

7

Lipid and carbohydrate based adjuvant/carriers in immunology.

McGeary RP, Olive C, Toth I. McGeary RP, et al. Among authors: toth i. J Pept Sci. 2003 Jul;9(7):405-18. doi: 10.1002/psc.467. J Pept Sci. 2003. PMID: 12916638 Review.

8

Lipid core peptide technology and group A streptococcal vaccine delivery.

Olive C, Batzloff MR, Toth I. Olive C, et al. Among authors: toth i. Expert Rev Vaccines. 2004 Feb;3(1):43-58. doi: 10.1586/14760584.3.1.43. Expert Rev Vaccines. 2004. PMID: 14761243 Free article. Review.

9

Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Among authors: toth i. Indian J Med Res. 2004 May;119 Suppl:88-94. Indian J Med Res. 2004. PMID: 15232170

10

Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage.

Horváth A, Olive C, Karpati L, Sun HK, Good M, Toth I. Horváth A, et al. Among authors: toth i. J Med Chem. 2004 Jul 29;47(16):4100-4. doi: 10.1021/jm040041w. J Med Chem. 2004. PMID: 15267249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,009 results

Search Page

Filters